LindaClaudetteStorkMD

Pediatric Hematology & Oncology • Portland, OR

Associate Professor of Pediatrics, Oregon Health & Sci University

Join to view full profile

Dr. Stork is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stork's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd

Portland, OR 97239
Phone+1 503-494-0829

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 1982 - 1986
University of ColoradoResidency, Pediatrics, 1981 - 1982
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1979 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979

Certifications & Licensure

WA State Medical License 2023 - 2026
OR State Medical License 2002 - 2025
CO State Medical License 1982 - 2003
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Portland Monthly Magazine Castle Connolly, 2011

Clinical Trials

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 1996 May 01
Completed
Phase 3
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors Start of enrollment: 2003 Oct 01
Completed
Phase 1
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2005 Apr 11
Completed
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
ACTIVE_NOT_RECRUITING
PHASE3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28
Completed
Phase 1, Phase 2
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Start of enrollment: 2020 Oct 02
RECRUITING
PHASE1
Roles: Contact
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
ACTIVE_NOT_RECRUITING
EARLY_PHASE1
Roles: Contact
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas Start of enrollment: 2019 Apr 03
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

8 citations
Functional impact and targetability of,, andmutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.
Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn S Nicholson, Lara Davis
Cold Spring Harbor Molecular Case Studies. 2022-01-01
24 citations
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
Leonard A. Mattano, Meenakshi Devidas, Kelly W. Maloney, Cindy Wang, Alison M. Friedmann
Journal of Clinical Oncology. 2021-03-19
7 citations
Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.
Kellee Parker, Erika Cottrell, Linda C. Stork, Susan Lindemulder
Pediatric Blood & Cancer. 2021-01-26

Grant Support

CCG 2961: Children W/ Untreated AML Immune Modulation Phase W/ IL 2National Center For Research Resources1999–2000
Pilot Trial With 6 ThioguanineNational Center For Research Resources1996–1997

LindaClaudetteStorkMD

Dr. Stork is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Grant Support

Viewing the full profile is available to verified healthcare professionals only.